一种统一的方法合成四种可能导致血小板缺血的线化物代谢物
Naoki Oikawa1, Natsu Inoue1, Shogo Ishii1
1Laboratory of Medicinal Chemistry, School of Pharmacy, Nihon University, 7-7-1, Narashinodai, Funabashi 274-8555, Chiba, Japan.
Pharmaceuticals (Basel, Switzerland)
|December 31, 2025
概括
研究人员合成了四种关键的线化物代谢物,有助于研究其有毒副作用,如细胞缺陷症患者的血栓塞缩症. 这项工作为进一步研究提供了关键的化合物.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 有机合成 有机合成
背景情况:
- 林尼佐利德是一种有效的抗生素对抗格兰阳性病原体的oxazolidinone.
- 临床使用受到血液学毒性的限制,特别是功能障碍中的血栓细胞减小.
- 怀疑代谢物积累,但毒性机制的细节尚不清楚.
研究的目的:
- 为四种主要的线化物代谢产物建立一种新的合成途径.
- 合成PNU-142618,142300,142586,和173558.8. 这些数字是
- 为药理动力学和毒理学研究提供化合物.
主要方法:
- 使用的氨酸衍生物是用2 - 二硫 (Ns) 组保护的.
- 为了高效的合成,采用选择性N-化.
- 获得的目标代谢物含有碳素酸组作为盐.
主要成果:
- 成功合成了四种线化物代谢物.
- 使用 Ns 策略实现了选择性的 N-化.
- 首次报告了PNU-142618和173558.8的合成情况.
结论:
- 开发了一种有效的合成途径,用于四种线化物代谢物.
- 促进对必要化合物的获取,以便进一步研究.
- 能够进行全面的药理动力学和毒理学研究.
关键词:
美国的战略和战略.PNU-142300 美国人民共和国PNU-14258686 是一个国家.PNU-14261818 这是一个很大的问题.PNU-17355858 是一个国家.在线zolidlid是什么意思代谢产物的代谢产物综合合成是一种合成.更多相关视频
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
8.3K
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
5.3K
相关概念视频
Drug Biotransformation: Overview
2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K
Drug Biotransformation: Overview
3.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.5K
Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Drug Metabolism: Phase I Reactions
4.5K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.5K
